Maccecchini Maria-Luisa 4
4 · Annovis Bio, Inc. · Filed Jan 18, 2022
Insider Transaction Report
Form 4
Maccecchini Maria-Luisa
DirectorPresident & CEO
Transactions
- Exercise/Conversion
Stock Option (right to buy)
2022-01-14−32,959→ 52,755 totalExercise: $0.14Exp: 2027-04-01→ Common Stock (32,959 underlying) - Exercise/Conversion
Common Stock
2022-01-14$0.14/sh+32,959$4,614→ 987,734 total
Footnotes (1)
- [F1]All of the shares underlying the option are fully vested and exercisable.